<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Included in the sequence of events leading to neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in ischemic tissue following <z:hpo ids='HP_0001297'>stroke</z:hpo> is an excessive and toxic rise in the intracellular Ca(2+)-concentration, predominantly due to an influx of <z:chebi fb="0" ids="29108">Ca2+</z:chebi> through nonselective <z:chebi fb="36" ids="36916">cation</z:chebi>-channels as well as Ca(2+)-channels </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study we have characterized the pharmacological profile and anti-ischemic effects of 2-amino-1-(4-chlorobenzyl)-5-trifluoromethylbenzimidazole (NS-638), a small nonpeptide molecule with Ca(2+)-channel blocking properties </plain></SENT>
<SENT sid="2" pm="."><plain>NS-638 dose dependently inhibited <z:chebi fb="0" ids="29103">K(+)</z:chebi>-stimulated [45Ca2+]-uptake in chick cortical synaptosomes and 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)<z:chebi fb="0" ids="30768">propionic acid</z:chebi> (AMPA)-stimulated [3H]<z:chebi fb="3" ids="16865">GABA</z:chebi>-release from cultured cortical neurons with IC50 values of 2.3 and 4.3 microM, respectively </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="29103">K(+)</z:chebi>-stimulated intracellular Ca(2+)-elevation in cultured cerebellar granule cells was equipotently blocked with an IC50 value of 3.4 microM </plain></SENT>
<SENT sid="4" pm="."><plain>At this concentration no effect on Ca(2+)-induced contractions in <z:chebi fb="0" ids="29103">K(+)</z:chebi>-depolarized guinea pig taenia coli was observed </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of NS-638 on neuronal Ca(2+)-channels was evaluated using whole cell patch clamp techniques </plain></SENT>
<SENT sid="6" pm="."><plain>The compound reversibly blocked N- and L-type Ca(2+)-channels in cultured chick dorsal root ganglion cells in the concentration range of 1-30 microM </plain></SENT>
<SENT sid="7" pm="."><plain>In the mouse middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model, NS-638 administered i.p </plain></SENT>
<SENT sid="8" pm="."><plain>(50 mg kg-1) at 1 h and 6 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and once a day for the next two days, resulted in a 48% reduction in total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="9" pm="."><plain>The compound did not show protection against ischemic neuronal damage in the gerbil model of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) </plain></SENT>
<SENT sid="10" pm="."><plain>This data suggests, that neuronal Ca(2+)-channel blockers may have potential in ameliorating the pathological damage after focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>